Nyumbani › Ugonjwa wa Graves
Majaribio ya kliniki ya Ugonjwa wa Graves yanayovutia washiriki nchini Marekani
Masomo 15 ya Ugonjwa wa Graves yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- Dallas, TXUtafiti 7
- Miami, FLUtafiti 7
- Houston, TXUtafiti 6
- San Antonio, TXUtafiti 6
- Raleigh, NCUtafiti 3
- Hialeah, FLUtafiti 3
- Tucson, AZUtafiti 3
- El Paso, TXUtafiti 3
- Torrance, CAUtafiti 3
- San Francisco, CAUtafiti 3
- Havelock, NCUtafiti 3
- McKinney, TXUtafiti 3
- Doral, FLUtafiti 3
- Memphis, TNUtafiti 3
- Kansas City, MOUtafiti 3
- Las Vegas, NVUtafiti 3
- Farmington Hills, MIUtafiti 3
- Akron, OHUtafiti 3
- Baltimore, MDUtafiti 3
- Asheville, NCUtafiti 3
Kwa jimbo
- ArizonaUtafiti 5
- CaliforniaUtafiti 9
- FloridaUtafiti 8
- GeorgiaUtafiti 5
- KansasUtafiti 4
- KentuckyUtafiti 3
- MarylandUtafiti 4
- MichiganUtafiti 4
- MissouriUtafiti 3
- NevadaUtafiti 4
- New YorkUtafiti 5
- North CarolinaUtafiti 8
- OhioUtafiti 4
- PennsylvaniaUtafiti 3
- TennesseeUtafiti 4
- TexasUtafiti 8
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07722546Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
InaajiriHatua 3
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT07661056NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
InaajiriHatua 1
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07305818A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT07570316Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 4 Sep 2026 · NCT07682896A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT07018323A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT06727604Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 11 Ago 2026 · NCT07753603Preoperative Corticosteroids in Autoimmune Thyroid Disease
InaajiriHatua 4
Umri 18 na zaidi · Jinsia zote · Imesasishwa 5 Ago 2026 · NCT05435547Study of BHV-1300 in Graves' Disease
InaajiriHatua 1
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 31 Jul 2026 · NCT06980649Telehealth Music Therapy for Adults With Endocrine Disorder and Depression
Inaajiri
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 30 Jul 2026 · NCT07413874Evaluating an AI Tool for Detecting Thyrotoxic States
InaajiriUtafiti wa uchunguzi
Umri 22 na zaidi · Jinsia zote · Imesasishwa 1 Jun 2026 · NCT07017907Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease
InaajiriHatua 2
Umri 9 hadi 17 · Jinsia zote · Imesasishwa 27 Jan 2026 · NCT07369063Personalized Treatment in Thyroid Disorders
Inaajiri
Umri 21 hadi 65 · Jinsia zote · Imesasishwa 15 Okt 2025 · NCT03517579The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Feb 2024 · NCT06275373Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.